前言:给 33 的每日文献推送。mua

因为姗姗的基础文献看了很多了 本计划暂停啦~


# 2022/11/1

  • The role of FOXO1 in β-cell failure and type 2 diabetes mellitus
  • Diabetes mellitus and the β cell: the last ten years

# 2022/11/2

  • Proximal Tubule Autophagy Differs in Type 1 and 2 Diabetes
  • Mechanism and medical implications of mammalian autophagy
  • Autophagy and Obesity and Diabetes

# 2022/11/3

  • Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms
  • Genetics of diabetes mellitus and diabetes complications
  • Notch and interacting signalling pathways in cardiac development, disease, and regeneration

# 2022/11/4

  • Stress and Obesity
  • Melanocortin-4 Receptor Signalling: Importance for Weight Regulation and Obesity Treatment

# 2022/11/8

  • Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics
  • Periodontitis and diabetes: a two-way relationship
  • Follow-up of blood-pressure lowering and glucose control in type 2 diabetes

# 2022/11/9

  • Global accessibility of therapeutics for diabetes mellitus
  • Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia
  • Exercise in adults with type 1 diabetes mellitus

# 2022/11/12

  • Dietary Nonheme, Heme, and Total Iron Intake and the Risk of Diabetes in Adults: Results From the China Health and Nutrition Survey
  • Iron influences on the Gut-Brain axis and development of type 2 diabetes
  • Mechanisms Linking Glucose Homeostasis and Iron Metabolism Toward the Onset and Progression of Type 2 Diabetes

# 2022/11/14

  • A central role for GRB10 in regulation of islet function in man
  • The PI3K Pathway in Human Disease

# 2022/11/15

  • 30 Years of NF-kB: A Blossoming of Relevance to Human Pathobiology
  • FGF/FGFR signaling in health and disease
  • Dietary Intake and Type 2 Diabetes

# 2022/11/16

  • Heterogeneity in diabetes mellitus: a lesson in the complexity of human disease
  • Glucagon receptor antagonists might stimulate β-cell expansion

# 2022/11/17

  • The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits
  • FGF/FGFR signaling in health and disease

# 2022/11/18

  • Insulin sensitive human adipocytes for in vitro studies
  • The burden and risks of emerging complications of diabetes mellitus
  • Dietary Intake and Type 2 Diabetes

# 2022/11/19

  • Modelling metabolic diseases and drug response using stem cells and organoids
  • AcroBATics: how dying brown adipocytes trigger browning
  • The role of iron in host–microbiota crosstalk and its effects on systemic glucose metabolism

# 2022/11/20

  • Endosomal trafficking in metabolic homeostasis and diseases
  • The ATP-binding cassette proteins ABCB1 and ABCC1 as modulators of glucocorticoid action

# 2022/11/21

  • Global accessibility of therapeutics for diabetes mellitus
  • FGF/FGFR signaling in health and disease

# 2022/11/22

  • Global accessibility of therapeutics for diabetes mellitus
  • Autophagy in metabolic disease and ageing

# 2022/11/23

  • A multi-omics roadmap of β-cell failure in type 2 diabetes mellitus
  • FGF/FGFR signaling in health and disease
  • Type 2 diabetes mellitus in older adults: clinical considerations and management

# 2022/11/24

  • A multi-omics roadmap of β-cell failure in type 2 diabetes mellitus
  • Damaging missense variants in IGF1R implicate a role for IGF-1 resistance in the etiology of type 2 diabetes

# 2022/11/25

  • Engineered Tregs prevent diabetes mellitus in mice
  • Pancreatic islet-specific engineered Tregs exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models

# 2022/11/26

  • Modelling metabolic diseases and drug response using stem cells and organoids
  • A global view of hypertensive disorders and diabetes mellitus during pregnancy

# 2022/11/27

  • T-bet+ B cells promote metabolic disease
  • B cells accumulate in adipose tissue and exacerbate metabolic disorder during obesity

# 2022/11/28

  • GLP1–oestrogen agonist protects β-cells from insulin-deficient diabetes mellitus
  • Efficacy of a glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and preclinical models of insulin-deficient diabetes

# 2022/11/29

  • Probing α-cell dysfunction in type 2 diabetes mellitus
  • Heterogenous impairment of a cell function in type 2 diabetes is linked to cell maturation state
更新于